In-situ hybridization for beta4 integrin subunit in node-negative invasive carcinoma of the breast

被引：0

作者：

Diaz, LK ^{[1
]}

Cristofanilli, M ^{[1
]}

Zhou, X ^{[1
]}

Welch, K ^{[1
]}

Smith, TL ^{[1
]}

Sneige, N ^{[1
]}

Sahin, A ^{[1
]}

Gilcrease, MZ ^{[1
]}

机构：

[1] MD Anderson Canc Ctr, Houston, TX USA

来源：

LABORATORY INVESTIGATION | 2003年 / 83卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

110

引用

页码：27A / 27A

页数：1

共 50 条

[31] COMPARATIVE GENOMIC HYBRIDIZATION (CGH) PREDICTS RECURRENCE IN NODE-NEGATIVE BREAST-CANCER [J].

ISOLA, J ;

CHU, L ;

KALLIONIEMI, O ;

FUQUA, S ;

HILSENBECK, S ;

CLARK, G ;

OSBORNE, K ;

WALDMAN, F .

JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, :247-247

[32] CHROMOSOME-17 ANALYSIS OF DUCTAL CARCINOMA IN-SITU OF THE BREAST BY FLUORESCENCE IN-SITU HYBRIDIZATION [J].

MURPHY, DS ;

GEORGE, WD ;

KAYE, SB ;

KEITH, WN .

BRITISH JOURNAL OF SURGERY, 1994, 81 (12) :1807-1807

[33] HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas [J].

Press, MF ;

Bernstein, L ;

Thomas, PA ;

Meisner, LF ;

Zhou, JY ;

Ma, YL ;

Hung, G ;

Robinson, RA ;

Harris, C ;

ElNaggar, A ;

Slamon, DJ ;

Phillips, RN ;

Ross, JS ;

Wolman, SR ;

Flom, KJ .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (08) :2894-2904

[34] Fluorescence in situ hybridization and immunohistochemical assays for HER-2/neu status determination -: Application to node-negative breast cancer [J].

Onody, P ;

Bertrand, F ;

Muzeau, F ;

Bièche, I ;

Lidereau, R .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2001, 125 (06) :746-750

[35] MANAGEMENT OF IN-SITU AND MINIMALLY INVASIVE BREAST-CARCINOMA [J].

FRYKBERG, ER ;

BLAND, KI .

WORLD JOURNAL OF SURGERY, 1994, 18 (01) :45-57

[36] Ductal Carcinoma In-Situ Associated with Triple-Negative Invasive Breast Carcinoma Is Often Immunohistochemically Distinct from Invasive Component [J].

Simon, R. A. ;

Karim, T. A. ;

Zhang, C. ;

Steinhoff, M. M. ;

Sung, C. J. ;

Quddus, M. R. .

CANCER RESEARCH, 2010, 70

[37] Lack of CD151/integrin alpha 3 beta 1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers [J].

Gong, Y. .

BREAST DISEASES, 2016, 27 (02) :132-132

[38] ADJUVANT CHEMOTHERAPY AND ENDOCRINE THERAPY FOR NODE-POSITIVE AND NODE-NEGATIVE BREAST-CARCINOMA [J].

ALBAIN, KS .

CLINICAL OBSTETRICS AND GYNECOLOGY, 1989, 32 (04) :835-857

[39] Invasive breast cancer amplifies lymphangiogenic signals in tumor microenvironment through integrin beta4 expressing cancer-associated fibroblasts [J].

Kim, Baek Gil ;

Choi, Yoon Pyo ;

Kang, Suki ;

Lee, Joo Hyun ;

Cho, Nam Hoon .

CANCER RESEARCH, 2013, 73

[40] Prediction of lymph node status utilizing selective genomic fluorescence in situ hybridization markers in invasive breast carcinoma [J].

Doeden, KS ;

Bocklage, T ;

Harris, C ;

Davis, L ;

Doherty, P ;

Hraber, P ;

Tang, L ;

Hall, B ;

Rabinowitz, I ;

Williams, T ;

Hozier, J .

MODERN PATHOLOGY, 2005, 18 :31A-31A

← 1 2 3 4 5 →